Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (Q739328)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis |
scientific article; zbMATH DE number 6617952
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis |
scientific article; zbMATH DE number 6617952 |
Statements
Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (English)
0 references
18 August 2016
0 references
PKPD modeling
0 references
HCV
0 references
mixture modeling
0 references
0.8406053
0 references
0 references
0.80137885
0 references
0.79696894
0 references
0.7965349
0 references
0.7898723
0 references
0.78842604
0 references
0.7758248
0 references
